KC
LBPS

Kepos Capital’s 4D Pharma PLC LBPS Stock Holding History

Kepos Capital’s Portfolio LBPS Stock Details LBPS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100,000
Closed -$483K – 647
2022
Q1 		$483K Hold
100,000
– – 0.04% 226
2021
Q4 		$545K Sell
100,000
-29,000
-22% -$196K 0.05% 258
2021
Q3 		$795K Buy
+129,000
New +$1.16M 0.05% 315

Other funds holding LBPS

RL
Ruffer LLP London, United Kingdom $2.44B AUM 44.75% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Capstone Investment Advisors
Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Kepos Capital's LBPS Position: Q2 2022 in Review

Kepos Capital sold out of 4D Pharma PLC (LBPS) in Q2 2022, closing a stake of 100,000 shares — an estimated $483K sold.

Kepos Capital first reported a position in LBPS in Q3 2021 and held it in 3 quarters. The position peaked at $795K in Q3 2021. 8 funds tracked by Wall St. Rank hold LBPS as of Q2 2022.

  • Kepos Capital reported no remaining 4D Pharma PLC position as of Q2 2022 after selling out during the quarter.
  • Kepos Capital sold 100,000 4D Pharma PLC shares in Q2 2022, an estimated $483K.
  • Kepos Capital first reported a position in 4D Pharma PLC in Q3 2021 and held it in 3 quarters.
  • Kepos Capital's 4D Pharma PLC position peaked at $795K in Q3 2021.
  • 8 funds tracked by Wall St. Rank held 4D Pharma PLC as of Q2 2022.

Based on Kepos Capital's 13F filing for Q2 2022, filed 12 Aug 2022.